Concepedia
Statistics
Publications
8
Citations
444
H-Index
Active since
1993
Affiliations
Abbott Fund(Current)
Abbott (United Kingdom)
The University of Texas MD Anderson Cancer Center
Yingna Cai is an author at Abbott Fund specializing in pharmacology, enzyme inhibition, and drug discovery.
Publications per year
1993–2006
In Vitro Antibacterial Potency and Spectrum of ABT-492, a New Fluoroquinolone
Angela M. Nilius, Linus L. Shen, Dena M. Hensey-Rudloff et al. · Antimicrobial Agents and Chemotherapy · 2003 · 113 citations · Full text
Life Sciences, Microbiology, Pharmacology +10
The Pharmacokinetics and Safety of ABT-751, a Novel, Orally Bioavailable Sulfonamide Antimitotic Agent: Results of a Phase 1 Study
Kenneth R. Hande, A. Hagey, Jordan Berlin et al. · Clinical Cancer Research · 2006 · 81 citations
Medicine, Oncology, Pharmacology +17
Inhibition and inactivation of murine hepatic ethoxy- and pentoxyresorufin O-dealkylase by naturally occurring coumarins
Yingna Cai, Daniel Bennett, Raghunathan V. Nair et al. · Chemical Research in Toxicology · 1993 · 54 citations
Medicine, Biochemistry, Pharmacology +7
Mechanism-Based Inactivation of Hepatic Ethoxyresorufin O-Dealkylation Activity by Naturally Occurring Coumarins
Yingna Cai, Wanda Baer‐Dubowska, Mike J. Ashwood-Smith et al. · Chemical Research in Toxicology · 1996 · 51 citations
Medicine, Pharmacology, Toxicology +16
Effect of O6-benzylguanine on alkylating agent-induced toxicity and mutagenicity. In Chinese hamster ovary cells expressing wild-type and mutant O6-alkylguanine-DNA alkyltransferases.
Yingna Cai, Michael H. Wu, Meng Xu‐Welliver et al. · PubMed · 2000 · 48 citations
Pharmacy, Oncology, Toxicology +17
1–5 of 8